Monolithic Power Systems Furthers Diversification Strategy with Sensima Technology Acquisition

Monolithic Power Systems (MPS), a leading fabless manufacturer of high-performance analog and mixed-signal semiconductors, today announced that it has acquired Sensima Technology SA (Sensima) located in Switzerland.

Sensima is a pre-revenue, developer of magnetic sensor technologies for angle measurements as well as three-dimensional magnetic field sensing. Sensima's patented magnetic angle sensors are used in rotary encoders, electronically commutated motors and a broad range of products. Combining Sensima's real time precision magnetic angle sensing with MPS's technologies could offer revolutionized solutions for key industries such as automotive, industrial and cloud computing.

"We are pleased with this high quality technology acquisition," said Michael Hsing, CEO and founder of MPS. "Sensima's unique technology will further our diversification strategy and create new opportunities with key customers."

MPS has acquired all of the outstanding shares of capital stock of Sensima. The purchase price includes an initial cash payment of $11.7 million and a subsequent cash earn-out payment of up to $8.9 million which will be based upon Sensima's achieving certain performance goals. Key employees will also be eligible to receive time-based and performance-based restricted stock units in connection with this transaction. A portion of the initial cash consideration payable to the stockholders will be placed into escrow under the terms of the acquisition agreement.

Source: http://www.monolithicpower.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.